Patents by Inventor Mobin Karimi

Mobin Karimi has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods and compositions for inactivating interleukin-2-inducible t-cell kinase (ITK)
    Patent number: 12729381
    Abstract: The present disclosure relates to compositions and methods for administering a subject in need thereof an effective amount of an inhibitor of interleukin-2-inducible T-cell kinase (ITK). In embodiments, the polypeptide of the present disclosure is characterized as an inhibitor and includes an amino acid sequence having at least 80% sequence identity to SEQ ID NO: 2, wherein the peptide inhibitor includes a phosphorylated tyrosine.
    Type: Grant
    Filed: April 9, 2021
    Date of Patent: September 8, 2026
    Assignee: The Research Foundation for the State University of New York
    Inventors: Mobin Karimi, Alaji Bah
  • METHODS AND COMPOSITIONS FOR INACTIVATING INTERLEUKIN-2-INDUCIBLE T-CELL KINASE (ITK)
    Publication number: 20230141417
    Abstract: The present disclosure relates to compositions and methods for administering a subject in need thereof an effective amount of an inhibitor of interleukin-2-inducible T-cell kinase (ITK). In embodiments, the polypeptide of the present disclosure is characterized as an inhibitor and includes an amino acid sequence having at least 80% sequence identity to SEQ ID NO: 2, wherein the peptide inhibitor includes a phosphorylated tyrosine.
    Type: Application
    Filed: April 9, 2021
    Publication date: May 11, 2023
    Inventors: Mobin Karimi, Alaji Bah